Usman Ammara, Patterson Andrew J, Sadat Umar, Tang Tjun Y, Graves Martin J, Gillard Jonathan H
University Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
University Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
J Stroke Cerebrovasc Dis. 2017 Apr;26(4):858-862. doi: 10.1016/j.jstrokecerebrovasdis.2016.10.034. Epub 2016 Nov 21.
Ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance (MR) imaging enables the identification of inflammation within the atheroma, predominantly by USPIO uptake by macrophages present in atherosclerotic tissue. Diabetic patients, however, may have dysfunctional macrophage activity, which may affect utilization of USPIO in identifying plaque inflammation in this patient cohort.
Fifteen diabetic and fifteen nondiabetic patients underwent USPIO-enhanced carotid MR imaging using 1.5T MR system. Pre- and post-USPIO carotid MR images were manually coregistered. The percentage decrease in the signal intensity after USPIO administration was calculated as a relative measure of the USPIO uptake.
Diabetic and nondiabetic patients had comparable demographics and comorbidities. The mean global, maximum quadrant, and maximum slice changes showing change in relative signal intensity as a result of USPIO administration were comparable for the two patient cohorts (P > .05).
USPIO can identify inflammatory burden with carotid atheroma in both diabetic and nondiabetic patients.
超小超顺磁性氧化铁(USPIO)增强磁共振(MR)成像能够识别动脉粥样硬化斑块内的炎症,主要是通过存在于动脉粥样硬化组织中的巨噬细胞摄取USPIO来实现。然而,糖尿病患者可能存在巨噬细胞功能障碍,这可能会影响在该患者群体中利用USPIO识别斑块炎症的效果。
15名糖尿病患者和15名非糖尿病患者使用1.5T MR系统接受了USPIO增强颈动脉MR成像检查。对注射USPIO前后的颈动脉MR图像进行手动配准。计算注射USPIO后信号强度的下降百分比,作为USPIO摄取的相对指标。
糖尿病患者和非糖尿病患者在人口统计学特征和合并症方面具有可比性。两个患者队列中,因注射USPIO导致的相对信号强度变化的平均整体、最大象限和最大层面变化具有可比性(P > 0.05)。
USPIO能够识别糖尿病患者和非糖尿病患者颈动脉粥样硬化斑块的炎症负荷。